The SWOG Difference | We support SWOG - what makes a SWOG cancer clinical trial unique? | By The Hope Foundation | Facebook
![nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting](https://mma.prnewswire.com/media/1089343/nCoup_Inc_Logo.jpg?p=twitter)
nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting
![Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0093775405000849-gr1.gif)
Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care
![Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy](https://storage.googleapis.com/accesswire/logos/subaccounts/square/31906.jpg?v=1)
Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy
![Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology - The Lancet Oncology Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology - The Lancet Oncology](https://www.thelancet.com/cms/attachment/80b30ace-34eb-4d0d-ad33-68795ebf051a/gr1_lrg.jpg)
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology - The Lancet Oncology
![Session 1A: Organization of the NCI Clinical Trials System | Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary |The National Academies Press Session 1A: Organization of the NCI Clinical Trials System | Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary |The National Academies Press](https://nap.nationalacademies.org/books/12535/gif/7.gif)
Session 1A: Organization of the NCI Clinical Trials System | Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary |The National Academies Press
![Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001](https://repository.escholarship.umassmed.edu/bitstream/handle/20.500.14038/51355/10712-Article%20Text-78657-2-10-20221028.pdf.jpg?sequence=4&isAllowed=y)